Literature DB >> 17396115

Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system.

E Parker1, L J Newby, C C Sharpe, S Rossetti, A J Streets, P C Harris, M J O'Hare, A C M Ong.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) largely results from mutations in the PKD1 gene leading to hyperproliferation of renal tubular epithelial cells and consequent cyst formation. Rodent models of PKD suggest that the multifunctional hormone insulin-like growth factor-1 (IGF-1) could play a pathogenic role in renal cyst formation. In order to test this possibility, conditionally immortalized renal epithelial cells were prepared from normal individuals and from ADPKD patients with known germline mutations in PKD1. All patient cell lines had a decreased or absence of polycystin-1 but not polycystin-2. These cells had an increased sensitivity to IGF-1 and to cyclic AMP, which required phosphatidylinositol-3 (PI3)-kinase and the mitogen-activated protein kinase, extracellular signal-regulated protein kinase (ERK) for enhanced growth. Inhibition of Ras or Raf abolished the stimulated cell proliferation. Our results suggest that haploinsufficiency of polycystin-1 lowers the activation threshold of the Ras/Raf signalling system leading to growth factor-induced hyperproliferation. Inhibition of Ras or Raf activity may be a therapeutic option for decreasing tubular cell proliferation in ADPKD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17396115      PMCID: PMC2493387          DOI: 10.1038/sj.ki.5002229

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  31 in total

1.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

Authors:  M J O'Hare; J Bond; C Clarke; Y Takeuchi; A J Atherton; C Berry; J Moody; A R Silver; D C Davies; A E Alsop; A M Neville; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 2.  The genetics and physiology of polycystic kidney disease.

Authors:  J P Calvet; J J Grantham
Journal:  Semin Nephrol       Date:  2001-03       Impact factor: 5.299

3.  Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells.

Authors:  M Sutters; T Yamaguchi; R L Maser; B S Magenheimer; P L St John; D R Abrahamson; J J Grantham; J P Calvet
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

4.  Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins.

Authors:  Stephen C Parnell; Brenda S Magenheimer; Robin L Maser; Christopher A Zien; Anna-Maria Frischauf; James P Calvet
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

5.  PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2.

Authors:  Anil Kumar Bhunia; Klaus Piontek; Alessandra Boletta; Lijuan Liu; Feng Qian; Pei Ning Xu; F Joseph Germino; Gregory G Germino
Journal:  Cell       Date:  2002-04-19       Impact factor: 41.582

6.  Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.

Authors:  H M Aukema; I Housini
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

7.  Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications.

Authors:  S Rossetti; L Strmecki; V Gamble; S Burton; V Sneddon; B Peral; S Roy; A Bakkaloglu; R Komel; C G Winearls; P C Harris
Journal:  Am J Hum Genet       Date:  2000-12-12       Impact factor: 11.025

8.  A complete mutation screen of the ADPKD genes by DHPLC.

Authors:  Sandro Rossetti; Dominique Chauveau; Denise Walker; Anand Saggar-Malik; Christopher G Winearls; Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

9.  cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells.

Authors:  Kazushige Hanaoka; William B Guggino
Journal:  J Am Soc Nephrol       Date:  2000-07       Impact factor: 10.121

10.  cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.

Authors:  T Yamaguchi; J C Pelling; N T Ramaswamy; J W Eppler; D P Wallace; S Nagao; L A Rome; L P Sullivan; J J Grantham
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

View more
  43 in total

1.  Inhibition of the P2X7 receptor reduces cystogenesis in PKD.

Authors:  Ming-Yang Chang; Jenn-Kan Lu; Ya-Chung Tian; Yung-Chang Chen; Cheng-Chieh Hung; Yi-Hui Huang; Yau-Hung Chen; Mai-Szu Wu; Chih-Wei Yang; Yi-Chuan Cheng
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

2.  The Polycystin-1, Lipoxygenase, and α-Toxin Domain Regulates Polycystin-1 Trafficking.

Authors:  Yaoxian Xu; Andrew J Streets; Andrea M Hounslow; Uyen Tran; Frederic Jean-Alphonse; Andrew J Needham; Jean-Pierre Vilardaga; Oliver Wessely; Michael P Williamson; Albert C M Ong
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

Review 3.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 4.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

5.  Fundamental insights into autosomal dominant polycystic kidney disease from human-based cell models.

Authors:  Caroline Weydert; Jean-Paul Decuypere; Humbert De Smedt; Peter Janssens; Rudi Vennekens; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2018-09-13       Impact factor: 3.714

Review 6.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

7.  Turner syndrome and autosomal dominant polycystic kidney disease.

Authors:  Rachel Styer; Matthew Stephen; Faris Hashim; Krista Birkemeier
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-11-16

8.  Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.

Authors:  Andrew J Streets; Tajdida A Magayr; Linghong Huang; Laura Vergoz; Sandro Rossetti; Roslyn J Simms; Peter C Harris; Dorien J M Peters; Albert C M Ong
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-11

9.  Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1.

Authors:  Kyung Lee; Sylvia Boctor; Laura M C Barisoni; G Luca Gusella
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

Review 10.  New treatments for autosomal dominant polycystic kidney disease.

Authors:  Ming-Yang Chang; Albert C M Ong
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.